Choosing the wrong CDMO, missing a tech transfer milestone, or building the wrong outsourcing model can set your program back by years. 3Kinnect Solutions brings the operational and strategic expertise you need to move faster with confidence.
Emerging biotech teams build breakthrough science, then hit a wall when it comes to manufacturing execution. These are the breakdowns we see — and solve — every day.
Without a structured evaluation process, RFPs go out without the right criteria, vendor visits reveal nothing useful, and you end up choosing on cost over fit.
Misaligned expectations, underdefined scopes, and no operational oversight turn tech transfer into a black hole — consuming budget and runway without progress.
Virtual biotechs and startups don't have a dedicated CMC or MSAT team. Manufacturing decisions get made reactively — and often wrong — when headcount can't keep up.
A single CDMO relationship might work for Phase 1, but commercial-scale strategy requires a manufacturing network built for redundancy, capacity, and future flexibility.
Generic templates don't capture what matters for biologics or ADCs. Without the right technical and operational questions, vendor proposals are impossible to compare meaningfully.
As you move toward IND filing or Series B, sophisticated investors want to see a credible, de-risked manufacturing plan — not a CDMO name dropped into a deck slide.
We don't hand you a framework and walk away. We work alongside your team to solve real manufacturing and outsourcing challenges — from day one through CDMO onboarding and beyond.
Objective evaluation frameworks, scoring criteria built for your modality, and independent due diligence.
Defined milestones, clear accountability, and the technical oversight to keep projects on track.
A defensible manufacturing narrative that holds up in due diligence — from Seed through Series C.
Fractional MSAT and CMC support for lean teams — without the cost or commitment of a full-time hire.
You're shortlisting CDMOs for a biologic or ADC program and need an objective evaluation process
A structured RFP process, customized scorecard, site visit protocols, and a selection recommendation backed by technical rigor
You're a virtual biotech with no internal CMC team and a CDMO relationship that's drifting
Fractional MSAT support, vendor governance frameworks, and the operational oversight to keep your program moving
You're scaling from Phase 1 to Phase 2/3 and need to build a manufacturing network strategy
A multi-CDMO network assessment, risk stratification, commercial readiness roadmap, and capacity planning guidance
From CDMO identification to commercial manufacturing readiness — every engagement is designed to reduce risk, accelerate timelines, and give your team the operational confidence to execute.
Structured identification, RFI/RFP development, technical due diligence, site visits, and objective vendor scoring for biologics and ADC programs.
End-to-end transfer planning, milestone tracking, cross-functional coordination, and hands-on oversight to ensure a seamless transition to your manufacturing partner.
Fractional manufacturing sciences and technology support — for lean teams who need embedded operational expertise without the full-time headcount.
Single-to-multi-CDMO network design, geographic and capacity risk assessment, commercial scale planning, and long-term supply chain resilience strategy.
Build-vs-buy analysis, outsourcing model design, vendor risk stratification, and governance frameworks that keep your external manufacturing relationships aligned.
Cross-functional program management for outsourced development — from IND-enabling studies through commercial manufacturing readiness.
We map your program stage, manufacturing challenges, and outsourcing goals in a focused 30-minute conversation.
We define scope, deliverables, and a customized engagement model — from project-based to fractional advisory.
We work alongside your team to deliver structured, actionable outputs — not slides that collect dust.
Retained advisory, vendor oversight, and embedded support to keep your manufacturing strategy on track through scale-up.

PhD · Founder & Principal Consultant
Dr. Drummond founded 3Kinnect Solutions to close the gap between breakthrough science and real-world manufacturing execution. With a PhD in Chemistry and a career built on leading CDMO selection initiatives, building outsourcing strategies for biotech programs, and managing complex external manufacturing relationships, Dr. Drummond brings a rare combination of scientific rigor and operational experience to every engagement.
Her background spans years of cancer research and hands-on work in CMC operations — giving her a first-hand understanding of what it takes to move a molecule from lab bench to manufacturing at scale. She has worked with virtual biotechs, emerging pharma, and development-stage companies navigating the full outsourcing lifecycle for biologics and antibody-drug conjugates.
Whether you're at the start of your CDMO search, in the middle of a stalled tech transfer, or building out your outsourcing model for scale — let's find out if we're the right fit for your program.
Your information is kept strictly confidential and will never be shared.